Pulmonary neuroendocrine tumors (NETs) are a heterogeneous group of neoplasms.
They can be divided into four categories: typical carcinoid, atypical carcinoid, and two highgrade subtypes -large cell neuroendocrine cancer and small cell lung carcinoma [1] .
Pulmonary carcinoids (PCs) are rare, although the incidence has been observed to increase in recent decades. We describe a case of a woman with symptomatic isolated cardiac metastases of PC found 13 years after surgical resection of the primary tumor.
The patient was diagnosed with the right middle lobe lung tumor at the age of 44. In December 2004 she underwent lobectomy with lymphadenectomy. Histopathological examination revealed pulmonary carcinoid (T1N0M0, IA). She was then followed with annual chest radiography.
In May 2017, the patient was referred to the emergency department for syncope. She complained of progressive dyspnea and fatigue over the past few days. Moreover, hypotension was present on admission (the mean arterial pressure 50 mmHg). Computed tomography (CT) angiography (performed to exclude pulmonary embolism) revealed pericardial and pleural effusion with a pathologic mass of the interventricular septum ( Figure   1A and 1B). To confirm the diagnosis of cardiac tamponade echocardiography was performed. It showed pericardial effusion (up to 20 mm), diastolic collapse of the right atrium and dilated inferior vena cava. The patient underwent pericardiocentesis to relieve symptoms.
Cardiac magnetic resonance imaging (MRI) after recovery revealed two lesion -in the interventricular septum ( Figure 1C ) and another one in the basal anterolateral segments of the heart ( Figure 1D ). 18F-FDG PET/CT showed hypermetabolic areas corresponding to MRI findings any without other sites suggestive of malignancy. Pericardiotomy with biopsy proved typical PC cardiac metastases (Ki67 5-10 %).
The patient was qualified for somatostatin analog therapy after confirming somatostatin receptors overexpression in the cardiac metastases ( Figure 1E and 1F) . The treatment started in September 2017. Since that time the patient has not presented any symptoms. Radiological control four months later demonstrated a response to the treatment ( Figure 1G and 1H ).
PCs may long be asymptomatic. Symptoms occurrence can result from local spread or metastases. An early manifestation is usually attributed to the secretion of humoral factors.
Cardiac symptoms typically result from carcinoid heart disease [2] . The most common sites of PC metastasis are the liver, bone, adrenal gland, or brain. To date, about 40 cases of NET metastases to the heart have been described, most of them in small bowel NETs [3] . However, the frequency of NET cardiac metastases may be underestimated, as functional imaging studies revealed a frequency between 2.4 and 13 % [4, 5] . Clinical presentation in such cases varies, from an asymptomatic course, through mild chronic symptoms (e.g., arrhythmias, exertional dyspnea), to severe life-threatening complications (acute heart failure, complete heart block, cardiac arrest, cardiogenic shock). Metastatic lesions are usually located in the ventricles or interventricular septum [3] . Cardiac metastases are usually expected in the case of multi-site metastatic disease.
This case points to a need for careful surveillance of NET patients, even many years after primary resection. Different imaging modalities, both morphologic and functional, may be needed.
